Clinica Universidad de Navarra (MAD) - Oncology Service

Madrid

0 studies enrolling now · 5 studies all time

What they study most

Head and Neck Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Uterine Cervical Neoplasms

Studies at this site

• Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302) — Running, not enrolling
• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) — Stopped early
• Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX) — Stopped early
• M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) — Stopped early
• Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer — Completed